Back
Royalty Pharma Plc Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
RPRX
Royalty Pharma Plc
Last Price:
$38.62
Seasonality Move:
3.43%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing slight buying pressure.
Royalty Pharma Plc Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.46 | Buy |
| 20-day SMA: | 39.02 | Sell |
| 50-day SMA: | 38.28 | Buy |
| 200-day SMA: | 35.47 | Buy |
| 8-day EMA: | 20.37 | Buy |
| 20-day EMA: | 9.97 | Buy |
| 50-day EMA: | 4.35 | Buy |
| 200-day EMA: | 1.14 | Buy |
Royalty Pharma Plc Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.23 | Buy |
| Relative Strength Index (14 RSI): | 49.22 | Sell |
| Chaikin Money Flow: | 1641258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.42 - 39.6) | Sell |
| Bollinger Bands (100): | (35.8 - 38.7) | Buy |
Royalty Pharma Plc Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Royalty Pharma Plc Stock
Is Royalty Pharma Plc Stock a Buy?
-
Royalty Pharma Plc share price is 38.60 while RPRX 8-day simple moving average is 38.46, which is a Buy signal.
-
The stock price of RPRX is 38.60 while Royalty Pharma Plc 20-day SMA is 39.02, which makes it a Sell.
-
Royalty Pharma Plc 50-day simple moving average is 38.28 while RPRX share price is 38.60, making it a Buy technically.
-
RPRX stock price is 38.60 and Royalty Pharma Plc 200-day simple moving average is 35.47, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
40
Royalty Pharma Plc (RPRX)
is a Sell
Is Royalty Pharma Plc a Buy or a Sell?
-
Royalty Pharma Plc stock is rated a SellThe current Royalty Pharma Plc [RPRX] share price is $38.60. The Score for RPRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma Plc Stock Info
Market Cap:
16.5B
Price in USD:
38.60
Share Volume:
5.3M
Royalty Pharma Plc 52-Week Range
52-Week High:
41.24
52-Week Low:
24.32
Sell
40
Royalty Pharma Plc (RPRX)
is a Sell
Royalty Pharma Plc Share Price Forecast
-
What is the Royalty Pharma Plc stock price today?The Royalty Pharma Plc stock price is 38.60 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma Plc> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma Plc overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma Plc is overvalued.
Is Royalty Pharma Plc Stock a Buy?
-
Royalty Pharma Plc share price is 38.60 while RPRX 8-day exponential moving average is 20.37, which is a Buy signal.
-
The stock price of RPRX is 38.60 while Royalty Pharma Plc 20-day EMA is 9.97, which makes it a Buy.
-
Royalty Pharma Plc 50-day exponential moving average is 4.35 while RPRX share price is 38.60, making it a Buy technically.
-
RPRX stock price is 38.60 and Royalty Pharma Plc 200-day simple moving average is 1.14, creating a Buy signal.
Fundamental Analysis of Royalty Pharma Plc
Is Royalty Pharma Plc a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.41 per share.
Technical Analysis of Royalty Pharma Plc
Should I short Royalty Pharma Plc stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 7.23, suggesting Royalty Pharma Plc is a Buy
-
Royalty Pharma Plc Relative Strength Index (RSI) is 49.22, which suggest Royalty Pharma Plc is oversold
-
The Bollinger Bands (25) for Royalty Pharma Plc is (38.42 - 39.6), which suggest Royalty Pharma Plc is a Buy
-
The Bollinger Bands (100) for Royalty Pharma Plc is (35.8 - 38.7), which suggest Royalty Pharma Plc is a Buy
* Royalty Pharma Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.